Multiple Sclerosis: Symptom Onset, Variability, and Disease Courses
Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the CNS. Onset typically 20–50 years (peak 30s); women 3:1.
Common Initial Presentations
- Optic neuritis (unilateral vision loss, pain with eye movement)
- Sensory: Numbness, tingling, band-like sensation (partial transverse myelitis)
- Motor: Weakness, spasticity, gait disturbance
- Brainstem: Diplopia (INO), vertigo, dysarthria, dysphagia
- Cerebellar: Ataxia, tremor, dysmetria
- Autonomic: Neurogenic bladder/bowel, sexual dysfunction
- Cognitive: Processing speed, memory, executive function
- Fatigue (80%), Uhthoff’s phenomenon (heat-worsening)
Disease Courses (2013 Phenotype)
- CIS: First demyelinating event; may or may not progress to MS.
- RRMS (85%): Relapses with full/partial remission; no progression between.
- SPMS: Initial RRMS then gradual progression ± relapses.
- PPMS (15%): Progression from onset; no distinct relapses.
Diagnosis
McDonald criteria: Dissemination in space (MRI lesions in ≥2 of 4 CNS regions) + dissemination in time (new lesion/enhancing lesion) + CSF oligoclonal bands.
Treatment
DMTs (disease-modifying therapies) reduce relapse rate, slow progression: interferons, glatiramer, S1P modulators, anti-CD20, natalizumab, cladribine, BTK inhibitors (emerging). Symptomatic management, rehab, wellness.
Multiple Sclerosis - Related Articles
- Understanding Multiple Sclerosis: Common Symptoms & What to Expect
- Causes of Multiple Sclerosis Itching and How to Treat It
- Scleroderma Symptoms: Early and Advanced Signs — A Comprehensive Guide
- How to Talk About Your Multiple Sclerosis Diagnosis with Family, Friends, and Work
- Managing MS Fatigue: Medications & Treatment Options
- Subchondral Sclerosis: Imaging, Pathophysiology & Link to Osteoarthritis
- Multiple Sclerosis (MS): Understanding Symptoms, Causes & the Central Nervous System
